Latest filing published 20 Feb 2024 for Icosavax, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Thomas Joseph Russo across 2 companies, led by Icosavax, Inc. and Assembly Biosciences, Inc. We count 12 filings; the first trade dates from 27 March 2020 and the latest from 19 February 2024.
No open-market purchase appears, only 7 sales worth €277k. Outside the open market, there are 4 share grants.
Most recently, on 20 February 2024, the filings show a transaction in Icosavax, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations